ABBVIE INC. vs. NewAmsterdam Pharma Company N.V. Ordinary Shares
ABBV
ABBVIE INC.
$293.30 +0.68%
VS NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
$18.90 +0.05%
ABBVIE INC. and NewAmsterdam Pharma Company N.V. Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | NAMS | |
|---|---|---|
| Market Cap | $514.92 billion | $2.27 billion |
ABBV leads on 1 of 1 size & scale factors.
Dividend
| ABBV | NAMS | |
|---|---|---|
| Dividend Yield | 2.48% | — |
ABBV and NAMS split the dividend factors evenly.
Risk & Sentiment
| ABBV | NAMS | |
|---|---|---|
| Short Interest | 0.85% | 0.01% |
NAMS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, NAMS overview, NAMS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.